Transplantation, Corneal Terminated Phase 4 Trials for Moxifloxacin (DB00218)

Also known as: Corneal Transplantation

IndicationStatusPhase
DBCOND0072811 (Transplantation, Corneal)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00764582Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant SurgeryBasic Science